Investors / Portugal / Lince Capital
Lince Capital
Venture capital · Lisbon, Portugal · Europe
Lince Capital is an independent venture capital firm registered and regulated by the Portuguese securities regulator CMVM. It sets up and manages venture capital and specialized investment funds, and also supports the management of its portfolio companies.
Invests inHealthcare & BiotechAI & Machine Learning
In its own wordsreal estatehealthcaretechnologyretailindustrialsmes
Your fit with Lince Capital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsLince Capital lists 9 checked portfolio companies on its own site and is named in 10 funding rounds, 3 of them as lead. Its most frequent entry is Series B, 50% of the companies with a known first round. Its largest themes are Healthcare & Biotech (29%), AI & Machine Learning (29%) and Enterprise Software (14%). 44% of its companies are based in United States. It invests most often alongside INCE Capital, Indico Capital Partners and Armilar Venture Partners.
Counts come from funding rounds that name Lince Capital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundLince Capital does not state its stages on its site, so only what it does is shown.
Show as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 0% |
| Series A | 38% |
| Series B | 50% |
| Growth | 13% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 6 | 1 |
| '26 | 4 | 2 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 19th | 9 companies |
| Recent activity | 82th | 4 rounds in 12 months |
| Early stage | 54th | 0% of entries at pre-seed or seed |
| Evidence | 52th | 0% of companies confirmed by a round |
| Sector focus | 48th | 29% in its largest sector |
| Reach | 70th | 4 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| INCE Capital | 3 |
| Indico Capital Partners | 3 |
| Armilar Venture Partners | 2 |
| Lilly Asia Ventures | 2 |
| Shilling | 2 |
| 33N Ventures | 1 |
| Beta Capital | 1 |
| Bonsai Partners | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers9100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 29% | 15% |
| AI & Machine Learning | 29% | 18% |
| Enterprise Software | 14% | 8% |
| E-commerce & Marketplaces | 7% | 6% |
| Consumer | 7% | 3% |
| Fintech | 7% | 12% |
| Space & Defense | 7% | 3% |
Co-investor network
who it backs companies with, and who they back togetherCompare Lince Capital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Lince Capital| Date | Company | Stage |
|---|---|---|
| 22 Oct 2026 | Series B Led | |
| 5 Aug 2026 | Series A Led | |
| 5 Aug 2026 | Series B | |
| 7 Jul 2026 | Series C+ | |
| 17 Nov 2025 | Series A | |
| 2 Oct 2025 | Round Led | |
| 22 Sept 2025 | Series B | |
| 16 Sept 2025 | Series A |
Round details for Lince Capital
Amounts, full round histories and every co-investor in Lince Capital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
9 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Avenzo Therapeutics develops next-generation oncology therapies to transform cancer treatment | Healthcare & Biotech | Sept 2025Series B | Funding round | |
| Bambusa Therapeutics develops next-generation bispecific antibodies to treat immunological and inflammatory disorders | Healthcare & Biotech | Nov 2025Series A | Funding round | |
| The company manufactures autonomous drones. | AI & Machine LearningAI & Machine Learning | Oct 2026Series B | Funding round | |
| BIZAY sells personalized products, including business cards, flyers, stickers, and clothing. | E-commerce & MarketplacesConsumer | Jul 2026Series C+ | Funding round | |
| Feedzai develops and provides a platform to prevent fraud and financial crime using artificial intelligence | FintechAI & Machine Learning | Oct 2025Round | Funding round | |
| Musiversal provides a subscription-based service for music creators to collaborate with talented musicians in live sessions | Enterprise SoftwareEnterprise Software | Sept 2025Series A | Funding round | |
| Neuraspace provides AI/ML solutions for space traffic management and collision avoidance for satellite companies | AI & Machine LearningSpace & Defense | Aug 2026Series B · 2 rounds | Funding round | |
| Nutrium provides employee nutrition and benefits software for companies | Healthcare & Biotech | Sept 2025Series A | Funding round | |
| Ronovo Surgical develops and provides a modular platform for surgical operations called Carina | Healthcare & Biotech | Sept 2025Series B | Funding round |
About this data
site last read 11 Nov 2026- Site
- lince-capital.com
- Last read
- 11 Nov 2026
- Watching since
- 7 Nov 2026
- Rounds since
- 5 Sept 2025
- Companies checked
- 9
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Lince Capital's profile as data
Pull Lince Capital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/lince-capital.com
# also
GET /v1/firms/lince-capital.com/portfolio
GET /v1/firms/lince-capital.com/coinvestors
GET /v1/firms/lince-capital.com/news